Incorporating New Guidelines into School-Based Asthma Management.

Jessica Michala Jindra, Angela Duff Hogan

Abstract readReview

In one paragraph

Review in Current allergy and asthma reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jessica Michala JindraDepartment of Pediatrics, Division of Allergy and Immunology, University of Wisconsin School of Medicine and Public Health-Madison, Madison, WI, USA.

Angela Duff HoganDepartment of Pediatrics, Division of Allergy and Immunology, Macon and Joan Brock Virginia Health Sciences at Old Dominion University, Eastern Virginia Medical School, Norfolk, VA, USA. angela.hogan@chkd.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of the reviewThe aim of this review is to identify barriers and provide solutions to the implementation of inhaled corticosteroid-formoterol as rescue therapy within schools. RECENT

findingsGINA guidelines in 2019 and NAEPP in 2020 recommended inhaled corticosteroids combined with formoterol for a rescue inhaler over the traditional short-acting beta-agonist. The findings discussed in this article describe the barriers to the implementation of inhaled corticosteroids combined with formoterol for a rescue inhaler in school systems. Traditional asthma action plans, school nursing and parental education, and differences in dosing are some barriers identified. This paper provides solutions for the barriers, including updating and individualizing asthma action plans and providing thorough education to all parties on appropriate dosing for ICS-formoterol inhalers.

Indexed as

Adrenal Cortex HormonesAnti-Asthmatic AgentsAsthmaFormoterol FumarateSchool Health ServicesAdministration, InhalationHumansPractice Guidelines as TopicSchoolsAdrenal Cortex HormonesAnti-Asthmatic AgentsFormoterol FumarateAsthma action plansGINA updatesSchool asthmaSchool nurse

Identifiers

PMID42287579

DOI10.1007/s11882-026-01282-5

PMCPMC13264570

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.